Antacids Market Expected to Reach $9.1 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Antacids Market," The antacids market size was valued at $6.7 billion in 2022, and is estimated to reach $9.1 billion by 2032, growing at a CAGR of 3.1% from 2023 to 2032.

Antacid is a medication used to counteract hydrochloric acid or gastric acid secreted in the stomach. This medication is available in different forms and can provide temporary relief for symptoms of indigestion, heartburn or acid reflux, stomach ulcers, and gastritis by neutralizing stomach acid. This surges the demand for antacids among patients with acid-related conditions.

In addition, aged individuals are more prone to acid-related conditions such as gastroesophageal reflux disease (GERD) and peptic ulcer disease. This is attributed to the fact that muscles that keep stomach acid from flowing back into the esophagus along with the lining of the stomach become weaker with age. For instance, some medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can irritate the lining of the stomach and increase the production of stomach acid. As a result, the demand for antacids and other medications to treat these conditions tends to increase as the geriatric population increases, thus augmenting the antacids market growth. 

Furthermore, easy availability of generic antacids is one of the antacids market trends that is contributing to the growth of the antacids market. Generic antacids are less expensive than the branded medications, and are becoming increasingly popular among consumers looking for more affordable treatment options for acid-related symptoms. This boosts the overall demand for antacids, as it becomes more affordable for people all around the globe. 

Depending on the mechanism of action, the market is segmented into systemic antacids and non-systemic antacids. The non-systemic antacids segment exhibited highest growth in terms of revenue in 2022, and is anticipated to continue this trend during the forecast period. This is attributed to the advantages offered by the non-systemic antacids over the systemic antacids. For instance, non-systemic antacids work quickly to provide almost immediate relief from symptoms of heartburn, indigestion, and acid reflux. In addition, these antacids are not absorbed into the bloodstream, and thus, have fewer side effects than systemic antacids. 

On the basis of formulation type, the market is categorized into tablets, liquids, and others. The tablets segment acquired the largest market share in 2022 due to the presence of major players in the market offering a wide range of antacid tablets. In addition, these antacid tablets are available in various sizes, shapes, and flavors, which increased their adoption in gastrointestinal disease treatment. Moreover, launch of chewable antacid tablets, which are convenient and easy-to-use for people who experience occasional heartburn, have contributed significantly to the generation of large market share in the antacid industry. 

On the other hand, the liquids segment is anticipated to grow at its fastest rate during the forecast period owing to ease of use and convenience offered by liquid antacids. Liquid antacids are easy to swallow and can be taken on-the-go, making them a popular choice for people who are looking for quick relief from heartburn or acid reflux. In addition, the growth of the liquid segment is also attributed to the availability of a wide range of flavors, which are highly palatable by all age groups.

By distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online providers. The drug stores & retail pharmacies segment dominated the antacids market in 2022 in terms of revenue. This is attributed to the fact that many people experience occasional heartburn or indigestion and prefer to purchase antacids over the counter rather than seeking a prescription medication or medical intervention. In addition, drug stores and pharmacies are often conveniently located and offer a wide range of antacid products, including tablets, liquids, and chewable tablets, making them a popular choice for consumers. 

However, the online providers segment is anticipated to grow at a fastest rate during the forecast period due to increase in penetration of e-commerce websites and online purchasing of medications. In addition, heavy discounts and doorstep delivery service offered by these sites are anticipated to drive the segment growth during the forecast period.  

Region wise, North America obtained the highest antacids market share in 2022 owing to rise in prevalence of gastrointestinal disorders and consumer awareness of antacids and self-medication among the population in this region. In addition, well-established distribution channels and developed healthcare infrastructure have contributed to the growth of the market in North America region.

On the other hand, Asia-Pacific is expected to witness the highest growth in the antacids market during the forecast period. This is attributed to the presence of high population base and surge in geriatric population suffering from gastrointestinal disorders. In addition, development of healthcare services and facilities is anticipated to expand the market in Asia-Pacific.

Key findings of the study
• By mechanism of action, the non-systemic antacids segment was highest contributor to the antacids industry in 2022 and is anticipated to drive the market during the forecast period.
• On the basis of formulation type, the tablets segment dominated the market in 2022, and the liquids segment is anticipated to grow at a fastest rate during the forecast period. 
• Depending on distribution channel, the drug stores & retail pharmacies segment led the market in 2022; however, the online providers are anticipated to grow at the highest CAGR during the forecast period.
• Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.